Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 750 of 1467 entries
View as:

An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00576667 Org: User:
Start: 01/31/08 End: 02/28/09 Due: 02/28/10

Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

Phase: N/A Priority: Normal
NCT ID: NCT00993382 Org: User:
Start: 09/30/09 End: 05/31/11 Due: 05/31/12

Dermacyd Infantile (Lactic Acid)- Compatibility.

Phase: N/A Priority: Normal
NCT ID: NCT00881374 Org: User:
Start: 02/28/09 End: 03/31/09 Due: 03/31/10

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)

Phase: N/A Priority: Normal
NCT ID: NCT02451137 Org: User:
Start: 06/16/15 End: 08/09/18 Due: 08/09/19

A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04502862 Org: User:
Start: 08/10/20 End: 11/10/23 Due: 11/10/24

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

Phase: N/A Priority: Normal
NCT ID: NCT02878603 Org: User:
Start: 10/06/16 End: 10/23/20 Due: 10/23/21

Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria

Phase: N/A Priority: Normal
NCT ID: NCT01378286 Org: User:
Start: 01/31/12 End: 06/30/13 Due: 06/30/14

RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00258921 Org: User:
Start: 03/31/04 End: 07/31/06 Due: 07/31/07

ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose Combination

Phase: N/A Priority: Normal
NCT ID: NCT01204580 Org: User:
Start: 12/31/10 End: 03/31/12 Due: 03/31/13

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01254279 Org: User:
Start: 12/31/10 End: 12/31/14 Due: 12/31/15

A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia

Phase: N/A Priority: Normal
NCT ID: NCT02635243 Org: User:
Start: 04/30/16 End: 11/30/16 Due: 11/30/17

Insulin Glulisine in Healthy Lean and Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00311077 Org: User:
Start: 04/30/04 End: - Due: -

A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03192345 Org: User:
Start: 06/09/17 End: 01/17/22 Due: 01/17/23

A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps

Phase: N/A Priority: Normal
NCT ID: NCT02912468 Org: User:
Start: 12/05/16 End: 07/05/18 Due: 07/05/19

Topic Compatibility Dermacyd Wipes - Lactoserum - Hygiene

Phase: N/A Priority: Normal
NCT ID: NCT00371852 Org: User:
Start: 05/31/06 End: - Due: -

Insulin Glargine in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00347100 Org: User:
Start: 06/30/06 End: - Due: -

Evaluation of Dupilumab in Children With Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02948959 Org: User:
Start: 04/21/17 End: 08/26/20 Due: 08/26/21

Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM

Phase: N/A Priority: Normal
NCT ID: NCT02227212 Org: User:
Start: 08/31/14 End: 11/30/14 Due: 11/30/15

Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00692640 Org: User:
Start: 05/31/08 End: 11/30/11 Due: 11/30/12

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05584670 Org: User:
Start: 11/29/22 End: 11/07/28 Due: 11/07/29

Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy

Phase: N/A Priority: Normal
NCT ID: NCT00542165 Org: User:
Start: 03/31/04 End: 12/31/04 Due: 12/31/05

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01298323 Org: User:
Start: 02/25/11 End: 03/13/25 Due: 03/13/26

A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02910518 Org: User:
Start: 02/17/17 End: 05/03/17 Due: 05/03/18

Dermacyd PH_DESILSTY_FL (Lactic Acid) - Photo Evaluation - Stay on Floral

Phase: N/A Priority: Normal
NCT ID: NCT00933842 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)

Phase: N/A Priority: Normal
NCT ID: NCT03849716 Org: User:
Start: 04/05/19 End: 09/30/26 Due: 09/30/27